Home/Immunovia/Tom King, MD, PhD

TK

Tom King, MD, PhD

Medical Director

Therapeutic Areas

Oncology Pancreatic Cancer

Immunovia Pipeline

Drug	Indication	Phase
PancreaSure	Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) in High-Risk Individuals	Commercial Preparation

Leadership Team at Immunovia

Jeff Borcherding

Chief Executive Officer

Norma Palma, PhD

VP, Clinical & Medical Affairs

Lisa Ford, PhD, HCLD

Clinical Lab Director

View full Immunovia profile